Skip to main content
Equibles

ALIVUS · Alivus Life Sciences Limited · Documents

Use ALIVUS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALIVUS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,460.60 INR +16.90 (+1.17%) At close · Nov 13
Rebalance outlook locked
Market Cap
179.32B INR
Shares
122.77M
Volume · Nov 13 600.13K Avg daily vol (3M) 242.47K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Oct 30, 2026
2026
Oct 30
Earnings call
Q2 FY27 revenue rises 16% as guidance is reiterated

Alivus Life Sciences Limited reported Q2 FY27 revenue of Rs. 682 crores, up 16% year-on-year, and reiterated FY27 revenue growth guidance of 10-12% and EBITDA margin guidance of 35-36%.

3 source passages
For Q2 FY27, revenue from operations stood at Rs. 682, a growth of 16% year-on-year. So, accordingly, we reiterate our FY27 revenue growth guidance of 10-12%. We are confident of delivering EBITDA margins in the 35-36% range in FY27. Open the document at this passage
Showing 1–3 of 3 documents